Beta Therapeutics logo — Beta Therapeutics they are developing therapeutics that modu...

Beta Therapeutics

Beta Therapeutics they are developing therapeutics that modulate the progression of inflammatory diseases.

Founded 2011 3 employees Venture round Biotechnology, Health Care +1

General Information

Company Name Beta Therapeutics
Founded Year 2011
Employees 3
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Beta Therapeutics. To contact Beta Therapeutics, visit betatherapeutics.com.au.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Beta Therapeutics compare?

A PDF of Beta Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Beta Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Beta Therapeutics

Beta Therapeutics is a biotechnology startup founded in 2011 with a focus on developing therapeutics that modulate the progression of inflammatory diseases. The company's dedication to the Biotechnology and Health Care industries underscores its commitment to addressing critical health challenges through innovative solutions. In February 11, 2014, Beta Therapeutics secured a Venture Round investment from ANU Connect Ventures, highlighting the confidence of industry players in the company's potential. As the startup continues to progress in its mission, it stands poised to make significant strides in the biopharmaceutical landscape.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
ANU Connect Ventures
11 Feb 2014

Beta Therapeutics Alternatives & Competitors

Beta Therapeutics vs
Upstream Bio
Upstream Bio United States

Developing treatments for inflammatory diseases

IPO
78 employees
Biotechnology, Health Care
Beta Therapeutics vs

Developing novel therapeutics for cardiopulmonary diseases

Seed
3 employees
Biotechnology, Health Care
Beta Therapeutics vs
Evommune
Evommune United States

Developing innovative therapies that target key drivers of chronic inflammatory diseases.

69 employees
Biotechnology, Health Care

FAQ About Beta Therapeutics

Beta Therapeutics they are developing therapeutics that modulate the progression of inflammatory diseases.
Beta Therapeutics was founded in 2011.
Beta Therapeutics operates in Biotechnology, Health Care and Health and Wellness.
Beta Therapeutics has approximately 3 employees.
Beta Therapeutics has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to Beta Therapeutics include Upstream Bio, Allinaire Therapeutics, Evommune, Tevard Biosciences, Aquinox Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Beta Therapeutics and Upstream Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Beta Therapeutics, https://bouncewatch.com/company/beta-therapeutics, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes